VIEMED HEALTHCARE, INC. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
VIEMED HEALTHCARE, INC. (VMD) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $2.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2026-06-30 was $2.03M, a 12.98% decline year-over-year.
- VIEMED HEALTHCARE, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2026-03-31 was $2.45M, a 6.80% increase year-over-year.
- VIEMED HEALTHCARE, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2025-09-30 was $2.18M, a 31.86% increase year-over-year.
- VIEMED HEALTHCARE, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2025-06-30 was $2.33M, a 49.58% increase year-over-year.
- VIEMED HEALTHCARE, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2025 was $9.11M, a 51.38% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2024 was $6.02M, a 28.44% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2023 was $4.68M, a 122.20% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2022 was $2.11M, a 121.20% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.03M 10-Q · filed 2026-08-03 | $4.48M derived: sum of 2 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $2.45M 10-Q · filed 2026-08-03 | |||
| 2025-12-31 | $9.11M 10-K · filed 2026-03-04 | |||
| 2025-09-30 | $2.18M 10-Q · filed 2025-11-05 | $4.51M derived: sum of 2 quarters · filed 2026-08-03 | $6.81M derived: sum of 3 quarters · filed 2026-08-03 | |
| 2025-06-30 | $2.33M 10-Q · filed 2026-08-03 | $4.63M derived: sum of 2 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $2.29M 10-Q · filed 2026-08-03 | |||
| 2024-12-31 | $6.02M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $1.65M 10-Q · filed 2025-11-05 | $3.21M derived: sum of 2 quarters · filed 2025-11-05 | $4.53M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $1.56M 10-Q · filed 2025-11-05 | $2.88M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $1.32M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $4.68M 10-K · filed 2026-03-04 | |||
| 2023-09-30 | $1.19M 10-Q · filed 2024-11-06 | $2.36M derived: sum of 2 quarters · filed 2024-11-06 | $3.40M derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | $1.17M 10-Q · filed 2024-11-06 | $2.21M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $1.04M 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $2.11M 10-K · filed 2025-03-10 | |||
| 2022-09-30 | $542.00K 10-Q · filed 2023-11-01 | $1.06M derived: sum of 2 quarters · filed 2023-11-01 | $1.54M derived: sum of 3 quarters · filed 2023-11-01 | |
| 2022-06-30 | $514.00K 10-Q · filed 2023-11-01 | $999.00K derived: sum of 2 quarters · filed 2023-11-01 | ||
| 2022-03-31 | $485.00K 10-Q · filed 2023-11-01 | |||
| 2021-12-31 | $953.00K 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $251.00K 10-Q · filed 2022-11-01 | $489.00K derived: sum of 2 quarters · filed 2022-11-01 | $718.00K derived: sum of 3 quarters · filed 2022-11-01 | |
| 2021-06-30 | $238.00K 10-Q · filed 2022-11-01 | $467.00K derived: sum of 2 quarters · filed 2022-11-01 | ||
| 2021-03-31 | $229.00K 10-Q · filed 2022-11-01 | |||
| 2020-12-31 | $1.07M 10-K · filed 2022-03-07 | |||
| 2020-09-30 | $289.00K 10-Q · filed 2021-11-02 | $552.00K derived: sum of 2 quarters · filed 2021-11-02 | $812.00K derived: sum of 3 quarters · filed 2021-11-02 | |
| 2020-06-30 | $263.00K 10-Q · filed 2021-11-02 | $523.00K derived: sum of 2 quarters · filed 2021-11-02 | ||
| 2020-03-31 | $260.00K 10-Q · filed 2021-11-02 | |||
| 2019-12-31 | $1.24M 10-K · filed 2021-03-03 | |||
| 2019-09-30 | $319.00K 10-Q · filed 2020-11-04 | $648.00K derived: sum of 2 quarters · filed 2020-11-04 | $950.00K derived: sum of 3 quarters · filed 2020-11-04 | |
| 2019-06-30 | $329.00K 10-Q · filed 2020-11-04 | $631.00K derived: sum of 2 quarters · filed 2020-11-04 | ||
| 2019-03-31 | $302.00K 10-Q · filed 2020-11-04 | |||
| 2018-12-31 | $1.90M 10-K · filed 2020-03-04 | |||
| 2018-09-30 | $467.00K 10-Q · filed 2019-11-05 | $903.00K derived: sum of 2 quarters · filed 2019-11-05 | $1.32M derived: sum of 3 quarters · filed 2019-11-05 | |
| 2018-06-30 | $436.00K 10-Q · filed 2019-11-05 | $852.00K derived: sum of 2 quarters · filed 2019-11-05 | ||
| 2018-03-31 | $416.00K 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |